Loading
Newborn sequencing programmes exclude adult cancer genes because babies cannot consent. Storing those results and offering them at 18 would preserve choice and give a lifetime of prevention.
Newborn sequencing programmes such as Genomics England's Generation Study exclude adult-onset cancer genes because babies cannot consent, so this idea sequesters actionable adult-onset variants in BRCA and Lynch genes and offers them for disclosure at 18 with counselling. This avoids re-sequencing, respects autonomy and captures carriers before cancer develops, so that they enter surveillance far earlier than through current diagnosis routes. The test is a pilot consent and disclosure protocol in an existing newborn genome cohort. Speculative in maturity, it addresses the bottleneck Inherited risk is mostly unidentified and links to germline testing and whole-genome sequencing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Whole-exome & whole-genome sequencing, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing.